Searchable abstracts of presentations at key conferences in endocrinology

ea0011p856 | Thyroid | ECE2006

Somatostatin receptor scintigraphy with 99mTc-HYNIC-TATE in visualization of non-radioiodine-avid differentiated thyroid carcinoma

Podgajny Z , Kaminski G , Szalus N , Kowalczyk A , Pietrzykowski J , Jaroszuk A , Siekierzynski M

Introduce: Lack of radioiodine uptake in Differentiated Thyroid Carcinoma (DTC) is a huge diagnostic and therapeutic problem. This sign is associated with worse prognosis. In patients with elevated thyroglobulin levels and with no evidence of disease on radioiodine scintigraphy, scintigraphy with somatostatin analogs can be an alternative imaging modality.The aim: Assessment of scintigraphy with the somatostatin analog 99mTc-HYNIC-TATE to visu...

ea0011p900 | Thyroid | ECE2006

Treatment of disseminated non-radioiodine - avid papillary thyroid cancer with 90Y-DOTA-TATE preparation

Szalus N , Kaminski G , Obuchowski K , Pietrzykowski J , Podgajny Z , Zagrodzka M , Dziuk E

Introduction: Lack of radioiodine uptake in Differentiated Thyroid Carcinoma is a huge diagnostic and therapeutic problem. This sign is associated with worse prognosis. DOTA-TATE preparation is a somatostatin analogue coupled with 90 Y which emites β (−) radiation. Its use in a treatment depends on excessive expression of somatostatin receptors (SSTR) in malignant tumours.The aim of the study: To present a possibility of treatment o...